47 results on '"Cuccurullo, Chiara"'
Search Results
2. Prognostic value of average real variability of systolic blood pressure in elderly treated hypertensive patients
3. Prognostic Impact of 24-Hour Pulse Pressure Components in Treated Hypertensive Patients Older Than 65 Years
4. Prediction of Masked Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring
5. Diabetes mellitus and thrombosis
6. Prognostic value of non‐resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring
7. Myocardial glutathione metabolic status in fat-fed rabbits
8. Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells
9. Determinants of platelet activation in hypertensives with microalbuminuria
10. Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation
11. Prediction of carotid plaques in hypertensive patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness
12. Cardiovascular risk and dietary sugar intake: is the link so sweet?
13. Soluble forms of RAGE in internal medicine
14. Association of clinic and ambulatory blood pressure with new‐onset atrial fibrillation: A meta‐analysis of observational studies
15. COX-2 and the vasculature: Angel or evil?
16. Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis
17. PROGNOSTIC VALUE OF MASKED UNCONTROLLED HYPERTENSION DEFINED BY DIFFERENT AMBULATORY BLOOD PRESSURE CRITERIA
18. A polymorphism n the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke
19. Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress
20. Prognostic Value of Masked Uncontrolled Hypertension Defined by Different Ambulatory Blood Pressure Criteria
21. Increased Expression of Transforming Growth Factor-β1 as a Stabilizing Factor in Human Atherosclerotic Plaques
22. A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke
23. Prognostic value of morning surge of blood pressure in middle‐aged treated hypertensive patients
24. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke
25. The latest interleukin: IL-33 the novelIL-1-family member is a potent mast cell activator
26. Ascorbic acid supplementation reduces oxidative stress and platelet biochemical function in type 2 diabetic patients. Relevance of ascorbic acid dosage and formulation
27. 4 Ascorbic acid supplementation reduces oxidative stress and platelet biochemical function in type 2 diabetic patients. Relevance of ascorbic acid dosage and formulation
28. Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells
29. Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques
30. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques
31. Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities
32. C0389 Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: Beneficial effects of iloprost
33. Bicarbonate-dependent, carbonate radical anion-driven tocopherol-mediated human LDL peroxidation: an in vitro and in vivo study
34. Prediction of carotid plaques in hypertensive patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness
35. Cardiovascular risk and dietary sugar intake: is the link so sweet?
36. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: Beneficial effects of iloprost
37. Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes
38. Association Between Prostaglandin E Receptor Subtype EP4 Overexpression and Unstable Phenotype in Atherosclerotic Plaques in Human
39. Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans
40. Balance Between PGD Synthase and PGE Synthase Is a Major Determinant of Atherosclerotic Plaque Instability in Humans
41. Blockade of the Angiotensin II Type 1 Receptor Stabilizes Atherosclerotic Plaques in Humans by Inhibiting Prostaglandin E 2 –Dependent Matrix Metalloproteinase Activity
42. Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty
43. The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques
44. Cardiac Events in Hypertensive Patients With Renal Artery Stenosis Treated With Renal Angioplasty or Drug Therapy: Meta-Analysis of Randomized Trials.
45. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.
46. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: Beneficial effects of iloprost
47. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.